Want to see AU:EPN full AI Analyst Report?
EPN Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EDT
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.02 - AU$0.04
Previous CloseN/A
Volume347.89K
Average Volume (3M)229.01K
Market Cap
AU$10.89M
Enterprise ValueAU$15.96
Total Cash (Recent Filing)AU$1.29M
Total Debt (Recent Filing)AU$8.69M
Price to Earnings (P/E)93.3
Beta-0.47
Next Earnings
Feb 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding389,104,000
10 Day Avg. Volume150,925
30 Day Avg. Volume229,012
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)6.55
Price to Sales (P/S)1.33
P/FCF Ratio-3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Margin RecoveryTTM revenue growth and gross-margin expansion indicate stronger scale and economics than the prior period. If retained, this improvement can support operating leverage and provide a firmer base for converting renewed demand into more durable earnings.
Positive Cash Flow TurnaroundThe move to positive operating and free cash flow is a meaningful improvement in business quality because it shows operations are beginning to fund themselves. Sustained cash generation would improve reinvestment capacity and reduce reliance on external financing.
Improved LeverageThe substantial reduction in debt-to-equity shows balance-sheet repair is underway, improving financial flexibility relative to the prior year. Although leverage remains high, continued deleveraging could lower financing pressure and strengthen resilience as profitability develops.
Bears Say
Operating Losses PersistRevenue and gross-margin gains have not yet translated into positive operating earnings, leaving the core business economically fragile. Persistent EBIT losses reduce internal funding capacity and make the recovery dependent on further execution and continued improvement in scale.
High Leverage And Thin CoverageEven after deleveraging, debt remains elevated relative to a business with negative operating profitability, while cash-flow coverage provides only a thin buffer. This combination can constrain capital allocation and increase vulnerability if earnings or cash generation weaken.
Unproven Profitability DurabilityThe recent rebound follows several years of substantial losses and deeply negative margins, while the current net margin remains minimal. That history suggests the improvement is not yet proven through a full cycle, leaving execution risk around sustaining profitability.
Epsilon Healthcare Limited News
EPN FAQ
What was Epsilon Healthcare Limited’s price range in the past 12 months?
Epsilon Healthcare Limited lowest share price was AU$0.02 and its highest was AU$0.04 in the past 12 months.
What is Epsilon Healthcare Limited’s market cap?
Epsilon Healthcare Limited’s market cap is AU$10.89M.
When is Epsilon Healthcare Limited’s upcoming earnings report date?
Epsilon Healthcare Limited’s upcoming earnings report date is Feb 26, 2027 which is in 153 days.
How were Epsilon Healthcare Limited’s earnings last quarter?
Epsilon Healthcare Limited released its earnings results on Aug 31, 2026. The company reported -AU$0.002 earnings per share for the quarter.
Is Epsilon Healthcare Limited overvalued?
According to Wall Street analysts Epsilon Healthcare Limited’s price is currently Overvalued.
Does Epsilon Healthcare Limited pay dividends?
Epsilon Healthcare Limited does not currently pay dividends.
What is Epsilon Healthcare Limited’s EPS estimate?
Epsilon Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epsilon Healthcare Limited have?
Epsilon Healthcare Limited has 389,104,000 shares outstanding.
What happened to Epsilon Healthcare Limited’s price movement after its last earnings report?
Epsilon Healthcare Limited reported an EPS of -AU$0.002 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Epsilon Healthcare Limited?
Currently, no hedge funds are holding shares in AU:EPN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epsilon Healthcare Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth AU$68.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
121.58%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Epsilon Healthcare Limited
Epsilon Healthcare Limited operates as an Australian-based healthcare and pharmaceutical firm, with significant operations also extending into Canada. Established in 2016 and headquartered in Sydney, the company specializes in several areas: manufacturing and distributing a range of hydroponic supplies, including equipment, materials, and vital nutrients; developing and providing medicinal cannabis products; and offering comprehensive, ready-to-implement solutions for cannabis cultivation. The company officially rebranded from THC Global Group Limited to Epsilon Healthcare Limited in February 2021.
Technical Analysis
Vita Life Sciences Limited
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―